Jones Robin L, Fisher Cyril, Al-Muderis Omar, Judson Ian R
Department of Medicine, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK.
Eur J Cancer. 2005 Dec;41(18):2853-60. doi: 10.1016/j.ejca.2005.07.023. Epub 2005 Nov 10.
Liposarcoma is one of the most common soft tissue sarcomas and has a number of different subtypes: well-differentiated; dedifferentiated; myxoid/round cell; and pleomorphic. However, the response of these subgroups to chemotherapy is not well documented. In this study, we have conducted a retrospective analysis of a prospectively maintained database of soft tissue sarcoma patients treated at the Royal Marsden Hospital. Eighty-eight liposarcoma patients who received chemotherapy between August 1989 and June 2004 were identified. The response rates to chemotherapy of the different histological subtypes and overall and progression free survival were investigated. Survival according to histological grade was also assessed. A statistically significant higher response rate to first-line chemotherapy was observed in patients with myxoid liposarcoma compared to de- and well-differentiated tumours, 48% (95%CI; 28-69) and 11% (95%CI; 2-29), P = 0.005. Similarly, those with myxoid liposarcoma had a significantly higher response rate compared to all other liposarcoma patients, 48% (95%CI; 28-69) and 18% (95%CI; 8-31). Patients with lower grade tumours had better overall survival. This retrospective analysis suggests that myxoid liposarcoma is relatively chemosensitive in comparison to a combination of other liposarcomas, and in particular de- and well-differentiated tumours. Further confirmation of these results should be sought by similar analyses of other databases.
脂肪肉瘤是最常见的软组织肉瘤之一,有多种不同亚型:高分化型;去分化型;黏液样/圆形细胞型;以及多形性。然而,这些亚组对化疗的反应尚无充分记录。在本研究中,我们对皇家马斯登医院前瞻性维护的软组织肉瘤患者数据库进行了回顾性分析。确定了1989年8月至2004年6月期间接受化疗的88例脂肪肉瘤患者。研究了不同组织学亚型对化疗的反应率以及总生存期和无进展生存期。还评估了根据组织学分级的生存率。与去分化型和高分化型肿瘤相比,黏液样脂肪肉瘤患者对一线化疗的反应率在统计学上显著更高,分别为48%(95%CI;28 - 69)和11%(95%CI;2 - 29),P = 0.005。同样,与所有其他脂肪肉瘤患者相比,黏液样脂肪肉瘤患者的反应率显著更高,分别为48%(95%CI;28 - 69)和18%(95%CI;8 - 31)。低级别肿瘤患者的总生存期更好。这项回顾性分析表明,与其他脂肪肉瘤(特别是去分化型和高分化型肿瘤)组合相比,黏液样脂肪肉瘤对化疗相对敏感。应通过对其他数据库的类似分析来进一步证实这些结果。